Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer
Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 1995-02, Vol.39 (2), p.445-452 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 452 |
|---|---|
| container_issue | 2 |
| container_start_page | 445 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 39 |
| creator | Cometta, A Zinner, S de Bock, R Calandra, T Gaya, H Klastersky, J Langenaeken, J Paesmans, M Viscoli, C Glauser, M P |
| description | Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.39.2.445 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_asm2_</sourceid><recordid>TN_cdi_pubmed_primary_7726513</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>7726513</sourcerecordid><originalsourceid>FETCH-LOGICAL-a2845-d9e81c4f71c990f6807666d079a761b07e7babdd3ea9fb0570a88396596166f3</originalsourceid><addsrcrecordid>eNp1Uktr3DAQdktLuk1767Wga6DeSn7I1qGHZUnTQCCl7F2M5fFaqS0ZSd6w-fXVPkgf0JMYvsd8jL4k-cDokrGs_rxarZe5WGbLoihfJgtGRZ3yUvBXyYJSztOipsWb5K33DzTOpaAXyUVVZbxk-eLF4rue0IHSw6BNGuDJNqACjGQaZk9g1D8jZsgOnY-zwi5SdKtH_IcAnuA4aacVCX00nPaks450GJUk4lsHZh6s2gc7oYmsCYJGEzx51KEnCoxCtySbHsmtCehMhK2BgaxM0KNWzjY6Tpuz99raQ-ygd0hunJ0nYrvDYnI9u4iAIfduC0Y_HW2OUX6gR3CqJ2BasnEIYYz7D7r1cfm75HUHg8f35_cy2Xy93qy_pXf3N7fr1V0KWV2UaSuwZqroKqaEoB2vacU5b2kloOKsoRVWDTRtmyOIrqFlRaGuc3H4EMZ5l18mX06209yM2KqYwcEgJ6dHcHtpQcu_EaN7ubU7yXhWlnXUfzrp40m8d9g9SxmVhz7I2AeZC5nJ2IdIvzrRwY-ZfLBzvOzg_8f9-Ge0Z-NzWSJOTnivt_2jdiijqQRQvy1-AVT10R8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer</title><source>PubMed Central (Open Access)</source><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>Cometta, A ; Zinner, S ; de Bock, R ; Calandra, T ; Gaya, H ; Klastersky, J ; Langenaeken, J ; Paesmans, M ; Viscoli, C ; Glauser, M P</creator><creatorcontrib>Cometta, A ; Zinner, S ; de Bock, R ; Calandra, T ; Gaya, H ; Klastersky, J ; Langenaeken, J ; Paesmans, M ; Viscoli, C ; Glauser, M P</creatorcontrib><description>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.39.2.445</identifier><identifier>PMID: 7726513</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Adolescent ; Adult ; Aged ; Agranulocytosis ; Agranulocytosis - drug therapy ; Amikacin ; Amikacin - therapeutic use ; Ceftazidime ; Ceftazidime - therapeutic use ; Child ; Child, Preschool ; Clinical Trial ; Drug Therapy, Combination ; Drug Therapy, Combination - adverse effects ; Drug Therapy, Combination - therapeutic use ; Female ; Fever ; Fever - drug therapy ; Humans ; Infant ; Male ; Middle Aged ; Neoplasms ; Neoplasms - complications ; Neoplasms - drug therapy ; Penicillanic Acid - analogs & derivatives ; Penicillanic Acid - therapeutic use ; Piperacillin - therapeutic use ; Piperacillin, Tazobactam Drug Combination ; Prospective Studies ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't</subject><ispartof>Antimicrobial Agents and Chemotherapy, 1995-02, Vol.39 (2), p.445-452</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a2845-d9e81c4f71c990f6807666d079a761b07e7babdd3ea9fb0570a88396596166f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC162558/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC162558/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7726513$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cometta, A</creatorcontrib><creatorcontrib>Zinner, S</creatorcontrib><creatorcontrib>de Bock, R</creatorcontrib><creatorcontrib>Calandra, T</creatorcontrib><creatorcontrib>Gaya, H</creatorcontrib><creatorcontrib>Klastersky, J</creatorcontrib><creatorcontrib>Langenaeken, J</creatorcontrib><creatorcontrib>Paesmans, M</creatorcontrib><creatorcontrib>Viscoli, C</creatorcontrib><creatorcontrib>Glauser, M P</creatorcontrib><title>Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Agranulocytosis</subject><subject>Agranulocytosis - drug therapy</subject><subject>Amikacin</subject><subject>Amikacin - therapeutic use</subject><subject>Ceftazidime</subject><subject>Ceftazidime - therapeutic use</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Clinical Trial</subject><subject>Drug Therapy, Combination</subject><subject>Drug Therapy, Combination - adverse effects</subject><subject>Drug Therapy, Combination - therapeutic use</subject><subject>Female</subject><subject>Fever</subject><subject>Fever - drug therapy</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasms</subject><subject>Neoplasms - complications</subject><subject>Neoplasms - drug therapy</subject><subject>Penicillanic Acid - analogs & derivatives</subject><subject>Penicillanic Acid - therapeutic use</subject><subject>Piperacillin - therapeutic use</subject><subject>Piperacillin, Tazobactam Drug Combination</subject><subject>Prospective Studies</subject><subject>Randomized Controlled Trial</subject><subject>Research Support, Non-U.S. Gov't</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1Uktr3DAQdktLuk1767Wga6DeSn7I1qGHZUnTQCCl7F2M5fFaqS0ZSd6w-fXVPkgf0JMYvsd8jL4k-cDokrGs_rxarZe5WGbLoihfJgtGRZ3yUvBXyYJSztOipsWb5K33DzTOpaAXyUVVZbxk-eLF4rue0IHSw6BNGuDJNqACjGQaZk9g1D8jZsgOnY-zwi5SdKtH_IcAnuA4aacVCX00nPaks450GJUk4lsHZh6s2gc7oYmsCYJGEzx51KEnCoxCtySbHsmtCehMhK2BgaxM0KNWzjY6Tpuz99raQ-ygd0hunJ0nYrvDYnI9u4iAIfduC0Y_HW2OUX6gR3CqJ2BasnEIYYz7D7r1cfm75HUHg8f35_cy2Xy93qy_pXf3N7fr1V0KWV2UaSuwZqroKqaEoB2vacU5b2kloOKsoRVWDTRtmyOIrqFlRaGuc3H4EMZ5l18mX06209yM2KqYwcEgJ6dHcHtpQcu_EaN7ubU7yXhWlnXUfzrp40m8d9g9SxmVhz7I2AeZC5nJ2IdIvzrRwY-ZfLBzvOzg_8f9-Ge0Z-NzWSJOTnivt_2jdiijqQRQvy1-AVT10R8</recordid><startdate>19950201</startdate><enddate>19950201</enddate><creator>Cometta, A</creator><creator>Zinner, S</creator><creator>de Bock, R</creator><creator>Calandra, T</creator><creator>Gaya, H</creator><creator>Klastersky, J</creator><creator>Langenaeken, J</creator><creator>Paesmans, M</creator><creator>Viscoli, C</creator><creator>Glauser, M P</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>19950201</creationdate><title>Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer</title><author>Cometta, A ; Zinner, S ; de Bock, R ; Calandra, T ; Gaya, H ; Klastersky, J ; Langenaeken, J ; Paesmans, M ; Viscoli, C ; Glauser, M P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a2845-d9e81c4f71c990f6807666d079a761b07e7babdd3ea9fb0570a88396596166f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Agranulocytosis</topic><topic>Agranulocytosis - drug therapy</topic><topic>Amikacin</topic><topic>Amikacin - therapeutic use</topic><topic>Ceftazidime</topic><topic>Ceftazidime - therapeutic use</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Clinical Trial</topic><topic>Drug Therapy, Combination</topic><topic>Drug Therapy, Combination - adverse effects</topic><topic>Drug Therapy, Combination - therapeutic use</topic><topic>Female</topic><topic>Fever</topic><topic>Fever - drug therapy</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasms</topic><topic>Neoplasms - complications</topic><topic>Neoplasms - drug therapy</topic><topic>Penicillanic Acid - analogs & derivatives</topic><topic>Penicillanic Acid - therapeutic use</topic><topic>Piperacillin - therapeutic use</topic><topic>Piperacillin, Tazobactam Drug Combination</topic><topic>Prospective Studies</topic><topic>Randomized Controlled Trial</topic><topic>Research Support, Non-U.S. Gov't</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cometta, A</creatorcontrib><creatorcontrib>Zinner, S</creatorcontrib><creatorcontrib>de Bock, R</creatorcontrib><creatorcontrib>Calandra, T</creatorcontrib><creatorcontrib>Gaya, H</creatorcontrib><creatorcontrib>Klastersky, J</creatorcontrib><creatorcontrib>Langenaeken, J</creatorcontrib><creatorcontrib>Paesmans, M</creatorcontrib><creatorcontrib>Viscoli, C</creatorcontrib><creatorcontrib>Glauser, M P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cometta, A</au><au>Zinner, S</au><au>de Bock, R</au><au>Calandra, T</au><au>Gaya, H</au><au>Klastersky, J</au><au>Langenaeken, J</au><au>Paesmans, M</au><au>Viscoli, C</au><au>Glauser, M P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>1995-02-01</date><risdate>1995</risdate><volume>39</volume><issue>2</issue><spage>445</spage><epage>452</epage><pages>445-452</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><abstract>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>7726513</pmid><doi>10.1128/AAC.39.2.445</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 1995-02, Vol.39 (2), p.445-452 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_pubmed_primary_7726513 |
| source | PubMed Central (Open Access); MEDLINE; EZB Electronic Journals Library |
| subjects | Adolescent Adult Aged Agranulocytosis Agranulocytosis - drug therapy Amikacin Amikacin - therapeutic use Ceftazidime Ceftazidime - therapeutic use Child Child, Preschool Clinical Trial Drug Therapy, Combination Drug Therapy, Combination - adverse effects Drug Therapy, Combination - therapeutic use Female Fever Fever - drug therapy Humans Infant Male Middle Aged Neoplasms Neoplasms - complications Neoplasms - drug therapy Penicillanic Acid - analogs & derivatives Penicillanic Acid - therapeutic use Piperacillin - therapeutic use Piperacillin, Tazobactam Drug Combination Prospective Studies Randomized Controlled Trial Research Support, Non-U.S. Gov't |
| title | Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T18%3A08%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_asm2_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Piperacillin-tazobactam%20plus%20amikacin%20versus%20ceftazidime%20plus%20amikacin%20as%20empiric%20therapy%20for%20fever%20in%20granulocytopenic%20patients%20with%20cancer.%20The%20International%20Antimicrobial%20Therapy%20Cooperative%20Group%20of%20the%20European%20Organization%20for%20Research%20and%20Treatment%20of%20Cancer&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=Cometta,%20A&rft.date=1995-02-01&rft.volume=39&rft.issue=2&rft.spage=445&rft.epage=452&rft.pages=445-452&rft.issn=0066-4804&rft.eissn=1098-6596&rft_id=info:doi/10.1128/AAC.39.2.445&rft_dat=%3Cpubmed_asm2_%3E7726513%3C/pubmed_asm2_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/7726513&rfr_iscdi=true |